Literature DB >> 193789

Human nasal epithelial cell culture system: evaluation of response to human interferons.

M W Harmon, S B Greenberg, P E Johnson, R B Couch.   

Abstract

This report describes the response of human nasal epithelial cells to exogenously applied human interferon (IF). To measure the response, a system developed to study human nasal epithelial cells in vitro was used. Nasal epithelial cells responded equally to both leukocyte and fibroblast IF, with development of resistance to virus replication that was time and dose dependent. Cells required contact with 1,000 U of IF (400 69/19 reference units) for 4 h to produce consistently a significant reduction in virus yield. This in vitro cell cultured system may be useful in predicting the in vivo response of human IF in respiratory viral infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193789      PMCID: PMC420977          DOI: 10.1128/iai.16.2.480-485.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Interferon.

Authors:  M Ho; J A Armstrong
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

2.  Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.

Authors:  W E Stewart II; P De Somer; V G Edy; K Paucker; K Berg; C A Ogburn
Journal:  J Gen Virol       Date:  1975-03       Impact factor: 3.891

3.  Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon.

Authors:  M W Harmon; S B Greenberg; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

4.  Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons.

Authors:  P E Came; T W Schafer; G H Silver
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

5.  Inhibition of respiratory virus infection by locally applied interferon.

Authors:  T C Merigan; S E Reed; T S Hall; D A Tyrrell
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

6.  Interferon and resistance to upper respiratory virus illness.

Authors:  T R Cate; R G Douglas; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

7.  Influence of oxygen and culture media on maintenance of whole hamster trachea organ cultures and replication of Sendai virus.

Authors:  L J Schiff; A M Shefner
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

8.  Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

9.  Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans.

Authors:  P E Johnson; S B Greenberg; M W Harmon; B R Alford; R B Couch
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

View more
  6 in total

1.  Antiviral activity of intranasally applied human leukocyte interferon.

Authors:  S B Greenberg; M W Harmon; P E Johnson; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

2.  Failure of human fibroblast interferon to protect against rhinovirus infection.

Authors:  G M Scott; S Reed; T Cartwright; D Tyrrell
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Purified interferon as protection against rhinovirus infection.

Authors:  G M Scott; R J Phillpotts; J Wallace; D S Secher; K Cantell; D A Tyrrell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

4.  Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.

Authors:  P R Wyde; C S Sun; S Z Wilson; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

5.  Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.

Authors:  S B Greenberg; H R Six; S Drake; R B Couch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Pulmonary deposition and clearance of aerosolized interferon.

Authors:  P R Wyde; S Z Wilson; M J Kramer; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.